TY - JOUR
T1 - Risk Factors for the Development of Cataract in Children with Uveitis
AU - Blum-Hareuveni, Tamar
AU - Seguin-Greenstein, Sophie
AU - Kramer, Michal
AU - Hareuveni, Guy
AU - Sharon, Yael
AU - Friling, Ronit
AU - Sharief, Lazha
AU - Lightman, Sue
AU - Tomkins-Netzer, Oren
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2017/5/1
Y1 - 2017/5/1
N2 - Purpose To determine the risk factors for the development of cataract in children with uveitis of any etiology. Design Cohort study. Methods Two hundred forty-seven eyes of 140 children with uveitis were evaluated for the development of vision-affecting cataract. Demographic, clinical, and treatment data were collected between the time of presentation and the first instance cataract was recorded or findings at final follow-up. Main outcome measures included the prevalence of cataract and distribution by type of uveitis, incidence of new onset cataract time to cataract development, and risk factors for the development of cataract. Results The prevalence of cataract in our cohort was 44.2% and was highest among eyes with panuveitis (77.1%), chronic anterior uveitis (48.3%), and intermediate uveitis (48.0%). The overall incidence of newly diagnosed cataract was 0.09 per eye-year, with an estimated 69% to develop uveitis-related cataract with time. The main factors related with cataract development were the number of uveitis flares per year (hazard ratio [HR] = 3.06 [95% confidence interval {CI}, 2.15–4.35], P <.001), cystoid macular edema (HR = 2.87 [95% CI, 1.41–5.82], P =.004), posterior synechia at presentation (HR = 2.85 [95% CI, 1.53–5.30], P = .001), and use of local injections of corticosteroids (HR = 2.37 [95% CI, 1.18–4.75], P =.02). Treatments with systemic and topical corticosteroids were not significant risk factors. Conclusions In this study, we found that development of cataract is common among pediatric eyes with uveitis and is most strongly related to the extent of inflammation recurrences and ocular complications. We suggest that controlling the inflammation, even using higher doses of systemic and topical corticosteroids, is of importance in preventing ocular complications, such as cataract.
AB - Purpose To determine the risk factors for the development of cataract in children with uveitis of any etiology. Design Cohort study. Methods Two hundred forty-seven eyes of 140 children with uveitis were evaluated for the development of vision-affecting cataract. Demographic, clinical, and treatment data were collected between the time of presentation and the first instance cataract was recorded or findings at final follow-up. Main outcome measures included the prevalence of cataract and distribution by type of uveitis, incidence of new onset cataract time to cataract development, and risk factors for the development of cataract. Results The prevalence of cataract in our cohort was 44.2% and was highest among eyes with panuveitis (77.1%), chronic anterior uveitis (48.3%), and intermediate uveitis (48.0%). The overall incidence of newly diagnosed cataract was 0.09 per eye-year, with an estimated 69% to develop uveitis-related cataract with time. The main factors related with cataract development were the number of uveitis flares per year (hazard ratio [HR] = 3.06 [95% confidence interval {CI}, 2.15–4.35], P <.001), cystoid macular edema (HR = 2.87 [95% CI, 1.41–5.82], P =.004), posterior synechia at presentation (HR = 2.85 [95% CI, 1.53–5.30], P = .001), and use of local injections of corticosteroids (HR = 2.37 [95% CI, 1.18–4.75], P =.02). Treatments with systemic and topical corticosteroids were not significant risk factors. Conclusions In this study, we found that development of cataract is common among pediatric eyes with uveitis and is most strongly related to the extent of inflammation recurrences and ocular complications. We suggest that controlling the inflammation, even using higher doses of systemic and topical corticosteroids, is of importance in preventing ocular complications, such as cataract.
UR - http://www.scopus.com/inward/record.url?scp=85015457288&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2017.02.023
DO - 10.1016/j.ajo.2017.02.023
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 28257832
AN - SCOPUS:85015457288
SN - 0002-9394
VL - 177
SP - 139
EP - 143
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
ER -